Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: fructose-6-phosphate amidotransferase in rat-1 fibroblasts - PubMed (original) (raw)
Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: fructose-6-phosphate amidotransferase in rat-1 fibroblasts
E D Crook et al. Diabetes. 1993 Sep.
Abstract
High glucose concentrations such as are seen in diabetes mellitus are known to have deleterious effects on cells, but the pathways by which glucose induces these effects are unknown. One hypothesis is that metabolism of glucose to glucosamine might be involved. For example, it has been shown that glucosamine is more potent than glucose in inducing insulin resistance in cultured adipocytes and in regulating the transcription of the growth factor transforming growth factor alpha in smooth muscle cells. The rate-limiting step in glucosamine synthesis is the conversion of fructose-6-phosphate to glucosamine-6-phosphate by the enzyme glutamine:fructose-6-phosphate amidotransferase. To test the hypothesis that this hexosamine biosynthesis pathway is involved in the induction of insulin resistance, we have overexpressed the enzyme glutamine:fructose-6-phosphate amidotransferase in Rat-1 fibroblasts and investigated its effects on insulin action in those cells. We electroporated Rat-1 fibroblasts with expression plasmids that did and did not contain the gene for glutamine:fructose-6-phosphate amidotransferase and measured glycogen synthase activity at varying insulin concentrations. Insulin stimulation was blunted in the glutamine:fructose-6-phosphate amidotransferase-transfected cells, resulting in decreased insulin sensitivity reflected by a rightward shift in the dose-response curve for activation of synthase (ED50 = 7.5 nM vs. 3.4 nM insulin, in glutamine:fructose-6-phosphate amidotransferase and control cells, respectively). Rat-1 fibroblasts incubated with 5.- mM glucosamine for 3 days exhibited a similar shift in the dose-response curve. The rightward shift in the dose-response curve is seen as early as 2 days after poration.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase.
Crook ED, Zhou J, Daniels M, Neidigh JL, McClain DA. Crook ED, et al. Diabetes. 1995 Mar;44(3):314-20. doi: 10.2337/diab.44.3.314. Diabetes. 1995. PMID: 7883119 - Regulation of glycogen synthase and protein phosphatase-1 by hexosamines.
Crook ED, McClain DA. Crook ED, et al. Diabetes. 1996 Mar;45(3):322-7. doi: 10.2337/diab.45.3.322. Diabetes. 1996. PMID: 8593937 - Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells.
Chen H, Ing BL, Robinson KA, Feagin AC, Buse MG, Quon MJ. Chen H, et al. Mol Cell Endocrinol. 1997 Nov 30;135(1):67-77. doi: 10.1016/s0303-7207(97)00191-3. Mol Cell Endocrinol. 1997. PMID: 9453242 - Hexosamines and insulin resistance.
McClain DA, Crook ED. McClain DA, et al. Diabetes. 1996 Aug;45(8):1003-9. doi: 10.2337/diab.45.8.1003. Diabetes. 1996. PMID: 8690144 Review. - Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG. Buse MG. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. doi: 10.1152/ajpendo.00329.2005. Am J Physiol Endocrinol Metab. 2006. PMID: 16339923 Free PMC article. Review.
Cited by
- Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
Dassanayaka S, Brittian KR, Long BW, Higgins LA, Bradley JA, Audam TN, Jurkovic A, Gumpert AM, Harrison LT, Hartyánszky I, Perge P, Merkely B, Radovits T, Hanover JA, Jones SP. Dassanayaka S, et al. PLoS One. 2020 Nov 30;15(11):e0242250. doi: 10.1371/journal.pone.0242250. eCollection 2020. PLoS One. 2020. PMID: 33253217 Free PMC article. - Discovery and Development of Small-Molecule Inhibitors of Glycogen Synthase.
Tang B, Frasinyuk MS, Chikwana VM, Mahalingan KK, Morgan CA, Segvich DM, Bondarenko SP, Mrug GP, Wyrebek P, Watt DS, DePaoli-Roach AA, Roach PJ, Hurley TD. Tang B, et al. J Med Chem. 2020 Apr 9;63(7):3538-3551. doi: 10.1021/acs.jmedchem.9b01851. Epub 2020 Mar 23. J Med Chem. 2020. PMID: 32134266 Free PMC article. - Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein _O_-GlcNAc Modification.
Chen Y, Zhao X, Wu H. Chen Y, et al. Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1911-1924. doi: 10.1161/ATVBAHA.119.312192. Epub 2019 Aug 29. Arterioscler Thromb Vasc Biol. 2019. PMID: 31462094 Free PMC article. Review. - A Genetic Model to Study Increased Hexosamine Biosynthetic Flux.
Hugo SE, Schlegel A. Hugo SE, et al. Endocrinology. 2017 Aug 1;158(8):2420-2426. doi: 10.1210/en.2017-00359. Endocrinology. 2017. PMID: 28582574 Free PMC article. - O-GlcNAc and the cardiovascular system.
Dassanayaka S, Jones SP. Dassanayaka S, et al. Pharmacol Ther. 2014 Apr;142(1):62-71. doi: 10.1016/j.pharmthera.2013.11.005. Epub 2013 Nov 25. Pharmacol Ther. 2014. PMID: 24287310 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases